Airfinity Biorisk
The world’s most comprehensive biorisk surveillance solution, providing real-time alerts and analysis on emerging outbreaks and infectious disease risks.
Real-time surveillance of 150+ diseases
The COVID-19 pandemic serves as a permanent reminder of the need for real-time infectious disease intelligence to better understand the current and future risk of different populations.
Airfinity Biorisk equips decision makers with a holistic overview of the global infectious disease risk situation, providing assessment and predictions for 150+ viral, bacterial and fungal pathogens to prevent the spread and subsequent impact of future outbreaks. A proprietary outbreak risk index is assigned to each new outbreak, based on 15+ metrics across country and disease level data points. Through expert analysis and assessment, we provide actionable insight into disease dynamics and forecasted disease burden in affected areas.
Daily Risk Alerts
A daily email alert with near real-time risk assessment of outbreaks worldwide, including any new changes in cases or any new variants detected.
24/7 Platform Access
Get access to a live Global Outbreaks Tracker, as well as real time epidemiological analysis and monitoring, all with extensive filtering options and downloadable data.
Global Risk Analysis & Forecasting
Airfinity Biorisk combines real-time data with dozens of risk metrics to create a number of easy to navigate tools and visualisations, giving you the information you need to get ahead of outbreaks, mitigate risk and prevent further negative health outcomes.
Near Real-Time Outbreak Tracker
Easy to use dashboard displaying the largest global infectious disease outbreaks over the last month. Every outbreak is assessed using a range of country and disease level metrics to determine risk, which is easily available for rapid evaluation. Time-series disease burden data is also available to showcase epidemiological trends.
Emergent Risk Models
Investigate the risk of variants and strains of pathogens of concern, for example SARS-CoV-2 and avian influenza. Over the pandemic Airfinity has been able to backtest the SARS-CoV-2 variant emergence tool as new variants have begun to circulate which been used to further validate the model.
Newsletters and Reports
Daily newsletters and weekly intelligence reports provide the information you need to make quick decisions. Identify new risks straight away and gain a more in-depth understanding thanks to our deep dives on topical diseases and outbreaks.
“Airfinity has been critical in furnishing us and the rest of the world with COVID-19 numbers.”
James Fransham, Data Journalist,
The Economist
“Airfinity has been instrumental in our country’s COVID response.”
Head of UK Government Vaccine Task Force
“Vaccine production data from Airfinity has been spot on. In a fast moving pandemic, these forecasts are really important for evidence-based policy making.”
Director General,
IFPMA
Get in touch
Fill out the below form to receive more information about Airfinity and our products.